Dyne Therapeutics WKN: A2QB6B ISIN: US26818M1080 Kürzel: DYN Forum: Aktien Thema: Hauptdiskussion

Dyne Therapeutics (Nasdaq: DYN) priced an upsized underwritten public offering of 18,980,478 common shares at $18.44 per share, expected to raise $350.0 million in gross proceeds before fees. The offering is expected to close on or about December 11, 2025, subject to customary closing conditions. Dyne sold all shares in the offering and granted underwriters a 30-day option to purchase up to an additional 2,847,071 shares at the public offering price, less underwriting discounts and commissions.

1.pos geöffnet

Nice, nice, nice… 30% 🤑😋

Zwischenergebnisse waren gut/ok, es war genau so prognostiziert! Somit ganz normale Vorgehensweise (wobei so stark nicht zu erwarten war, deswegen bin ich bei $25 rein 🤗).. selling on the good News 😁

warum gehst nach unten 🤔

Buying the Dip 😉👀